Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineage. Author(s): Lewnard JA, Mahale P, Malden D, Hong V, Ackerson BK, Lewin BJ, Link-Gelles R, Feldstein LR, Lipsitch M, Tartof SY|Journal: Nat Commun|PMID: 39362845| October 2024 The SARS-CoV-2 BA.2.86 lineage, and its sublineage JN.1 in particular, achieved widespread transmission in the US during winter 2023-24. However,…
